Ruth G. Shaw
Known title: DirectorCIK: 0001215486
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Truist lowers DTE Energy target to $150; Q3 2026 earnings date set. Truist Securities recently lowered its price target for DTE Energy to $150 while maintaining its positive stance. The company has also scheduled its third-quarter 2026 earnings release and conference call. Recent commentary highlights growing interest in DTE as U.S. power demand increases, providing context for the stock's current valuation.
Transaction History
| SPXC | ▲ Buy | Grant | 754 | — | 5/12/2026 | View on chart |
| SPXC | ▲ Buy | Grant | 892 | — | 5/13/2025 | View on chart |
| SPXC | ▲ Buy | Grant | 998 | — | 5/14/2024 | View on chart |
| SPXC | ▲ Buy | Grant | 1,770 | — | 5/9/2023 | View on chart |
| DTE | ▲ Buy | Option Exercise | 1,457 | $0 | 1/2/2023 | View on chart |
| DTE | ▼ Sell | Other | 1,457 | $171K | 1/2/2023 | View on chart |
| SPXC | ▲ Buy | Grant | 2,822 | — | 5/10/2022 | View on chart |
| DTE | ▲ Buy | Option Exercise | 1,560 | $0 | 1/2/2022 | View on chart |
| DTE | ▼ Sell | Other | 1,560 | $186K | 1/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
SPXC receives analyst coverage and growth focus
Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.
SPXC receives analyst coverage and growth focus. Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.